EP3455627A4 - Dispositifs et formulations permettant de détecter, sélectionner et surveiller des niveaux de certains constituants dans des fluides corporels, et procédé - Google Patents

Dispositifs et formulations permettant de détecter, sélectionner et surveiller des niveaux de certains constituants dans des fluides corporels, et procédé Download PDF

Info

Publication number
EP3455627A4
EP3455627A4 EP16898797.2A EP16898797A EP3455627A4 EP 3455627 A4 EP3455627 A4 EP 3455627A4 EP 16898797 A EP16898797 A EP 16898797A EP 3455627 A4 EP3455627 A4 EP 3455627A4
Authority
EP
European Patent Office
Prior art keywords
formulations
screening
detecting
devices
bodily fluids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16898797.2A
Other languages
German (de)
English (en)
Other versions
EP3455627A1 (fr
Inventor
Randice Lisa Altschul
Neil David THEISE
Myron Rapkin
Rebecca O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pop Test LLC
Original Assignee
Pop Test LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pop Test LLC filed Critical Pop Test LLC
Publication of EP3455627A1 publication Critical patent/EP3455627A1/fr
Publication of EP3455627A4 publication Critical patent/EP3455627A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/52—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91188—Transferases (2.) transferring nitrogenous groups (2.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP16898797.2A 2016-04-12 2016-04-12 Dispositifs et formulations permettant de détecter, sélectionner et surveiller des niveaux de certains constituants dans des fluides corporels, et procédé Withdrawn EP3455627A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/027108 WO2017180108A1 (fr) 2016-04-12 2016-04-12 Dispositifs et formulations permettant de détecter, sélectionner et surveiller des niveaux de certains constituants dans des fluides corporels, et procédé

Publications (2)

Publication Number Publication Date
EP3455627A1 EP3455627A1 (fr) 2019-03-20
EP3455627A4 true EP3455627A4 (fr) 2020-10-21

Family

ID=60042690

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16898797.2A Withdrawn EP3455627A4 (fr) 2016-04-12 2016-04-12 Dispositifs et formulations permettant de détecter, sélectionner et surveiller des niveaux de certains constituants dans des fluides corporels, et procédé

Country Status (2)

Country Link
EP (1) EP3455627A4 (fr)
WO (1) WO2017180108A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150241433A1 (en) * 2010-10-23 2015-08-27 Pop Test LLC Devices and Formulations for Detecting, Screening and Monitoring Levels of Certain Constituents in Bodily Fluids and Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1155944A1 (en) * 1981-08-03 1985-05-15 Ki Nii Endokrinologii Method of manufacturing indicating strips for determining glucose in blood
US5580744A (en) * 1992-04-27 1996-12-03 Avocet Medical, Inc. Test article and method for performing blood coagulation assays
US6524864B2 (en) * 2000-12-28 2003-02-25 Aurora L. Fernandez Decastro Test strip for simultaneous detection of a plurality of analytes
WO2005031351A1 (fr) * 2003-09-23 2005-04-07 Oakville Hong Kong Co., Limited Dispositifs de dosage a flux lateral et procedes d'utilisation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150241433A1 (en) * 2010-10-23 2015-08-27 Pop Test LLC Devices and Formulations for Detecting, Screening and Monitoring Levels of Certain Constituents in Bodily Fluids and Method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2017180108A1 *

Also Published As

Publication number Publication date
WO2017180108A1 (fr) 2017-10-19
EP3455627A1 (fr) 2019-03-20

Similar Documents

Publication Publication Date Title
EP3500153A4 (fr) Méthode et appareil permettant de déterminer un état de santé
EP3684248A4 (fr) Méthode et appareil permettant de déterminer un état de santé
EP3361239A4 (fr) Procédé, dispositif et équipement de détection de défaut d'affichage
EP3248544A4 (fr) Dispositif et procédé pour mesurer la concentration d'une substance dans le sang
EP3285081A4 (fr) Dispositif et procédé de détection d'état de fonctionnement de batterie
EP3344261A4 (fr) Systèmes et procédés pour surveillance de santé en continu au moyen d'un capteur d'analytes opto-enzymatique
EP3428669A4 (fr) Appareil et procédé de détection de l'état de santé d'une batterie
EP3377132A4 (fr) Systèmes, dispositifs et procédés de drainage et d'analyse de fluides corporels
EP3001196B8 (fr) Système et procédé de test de sang
EP3302240A4 (fr) Dispositif et procédé de détermination des taux d'indicateur biologique dans des tissus
EP3251056A4 (fr) Procédé et dispositif pour la détection de visage in vivo
EP3180611A4 (fr) Système et procédé de surveillance de santé sur la base d'un fluide corporel collecté
EP3332692A4 (fr) Procédé de mesure du champ visuel, appareil de mesure du champ visuel et optotype
EP3182901A4 (fr) Système et procédé d'analyse non-invasive de fluides corporels
EP3459457A4 (fr) Dispositif de mesure de la concentration sanguine en lipides et procédé de fonctionnement associé
EP3092029A4 (fr) Systèmes, dispositifs et procédés de drainage et d'analyse de fluides corporels
EP3226756A4 (fr) Appareil et procédé pour surveiller un état d'hypoglycémie
EP3282937A4 (fr) Méthode et appareil pour déterminer des marqueurs de santé par analyse de sang
EP3280325A4 (fr) Unité de détection de trouble neurologique et son procédé d'utilisation
EP3305482A4 (fr) Dispositif de diagnostic de défaillance et procédé de diagnostic de défaillance
EP3111216A4 (fr) Méthode et appareil de détermination de marqueurs de santé par analyse d'un échantillon de sang
EP3299132A4 (fr) Dispositif de diagnostic de défaillance et procédé de diagnostic de défaillance
EP3383473A4 (fr) Système et procédé de test sanguin
EP3100683A4 (fr) Dispositif de traitement de signaux photoacoustiques, système de traitement de signaux photoacoustiques et procédé de traitement de signaux photoacoustiques
EP3139151A4 (fr) Dispositif de mesure de concentration d'huile et procédé de mesure de concentration d'huile

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181107

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200918

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/00 20060101ALI20200914BHEP

Ipc: G01N 33/545 20060101ALI20200914BHEP

Ipc: G01N 33/52 20060101AFI20200914BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210417